Virbac loses bid to block generic animal drug

Intellectual Property 2025-01-07 12:50 pm By Cindy Cameronne | Sydney

Please login to bookmark

Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au